Targeting KRAS-mutant non-small-cell lung cancer: One mutation at a time, with a focus on KRAS G12C mutations

Timothy F. Burns, Hossein Borghaei, Suresh S. Ramalingam, Tony S. Mok, Solange Peters

Research output: Contribution to journalArticlepeer-review

35 Scopus citations
Original languageEnglish
Pages (from-to)4208-4218
Number of pages11
JournalJournal of Clinical Oncology
Volume38
Issue number35
DOIs
StatePublished - Dec 10 2020

Keywords

  • Carcinoma, Non-Small-Cell Lung/drug therapy
  • Humans
  • Lung Neoplasms/drug therapy
  • Models, Molecular
  • Molecular Targeted Therapy
  • Mutation
  • Protein Kinase Inhibitors/pharmacology
  • Proto-Oncogene Proteins p21(ras)/antagonists & inhibitors

Cite this